Metraipolis › archive › dc_b53b5522dfd2

ONC201/dordaviprone for H3 K27M-mutant tumors: Discovery, mechanisms, therapeutic potential, and future directions — Europe PMC PMID:42751161

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42751161
DOI
10.1016/j.gendis.2026.102335
License (as archived)
solo-consultazione
Archived
2026-10-19T04:01:22.255Z
SHA-256 of the archived text
7d5715fad09c0ffe8545d1771fd90af2005ebc96d95eaf643dafc0229982f414
Stable URL of this page
https://metraipolis.com/documento/dc_b53b5522dfd2

How to cite

ONC201/dordaviprone for H3 K27M-mutant tumors: Discovery, mechanisms, therapeutic potential, and future directions — Europe PMC PMID:42751161 — Europe PMC (en), https://europepmc.org/article/MED/42751161 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b53b5522dfd2 (Metraipolis archive dc_b53b5522dfd2, sha256 7d5715fad09c0ffe8545d1771fd90af2005ebc96d95eaf643dafc0229982f414)
BibTeX
@misc{dcb53b5522dfd2,
  title = {ONC201/dordaviprone for H3 K27M-mutant tumors: Discovery, mechanisms, therapeutic potential, and future directions — Europe PMC PMID:42751161},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42751161},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b53b5522dfd2; sha256 7d5715fad09c0ffe8545d1771fd90af2005ebc96d95eaf643dafc0229982f414},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42751161. Agents can read the archived copy with the MCP tool read_document.